These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1948754)

  • 1. [The mechanisms of the disorder of calcium homeostasis in terminal kidney failure and the allotransplantation of a cadaver kidney].
    Ermakova IP; Sokolova TIu; Pronchenko IA; Biriukova LS; Ermolenko AE; Levitskiĭ ER
    Ter Arkh; 1991; 63(6):75-8. PubMed ID: 1948754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The calcium-binding properties of plasma proteins following the allograft of a cadaveric kidney].
    Ermakova IP; Sokolova TIu; Pronchenko IA
    Biull Eksp Biol Med; 1990 Nov; 110(11):493-5. PubMed ID: 2083331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
    Ermakova IP; Novikov AI; Pronchenko IA; Sokolova TIu; Baeva LB; Ermolenko AE; Levitskiĭ ER
    Med Tekh; 1991; (1):27-9. PubMed ID: 2038254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The functional characteristics of the calcium-regulating systems and the calcium content of the blood following a cadaveric kidney allograft].
    Ermakova IP; Buzulina VP; Pronchenko IA; Ermolenko AE; Il'nitskiĭ VV
    Urol Nefrol (Mosk); 1993; (4):39-43. PubMed ID: 8310567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The calcium-binding properties of the plasma proteins from patients with aseptic necrosis of bone following a cadaveric kidney allograft].
    Sokolova TIu; Pronchenko IA; Biriukova LS; Sevost'ianov VA; Ermakova IP
    Biull Eksp Biol Med; 1993 Dec; 116(12):591-3. PubMed ID: 8123811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeostatic response to abrupt changes in plasma calcium level in chronic renal failure.
    Kaye M; Sagar S; Cohen GF; Potts JT; Murray T
    Isr J Med Sci; 1971 Mar; 7(3):521. PubMed ID: 5567545
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium in patients on hemodialysis.
    Ring T; Halkier P; Hansen HH; Sanden AK; Nielsen C
    Clin Nephrol; 1995 May; 43(5):332-4. PubMed ID: 7634549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease.
    Ferrari P; Singer R; Agarwal A; Hurn A; Townsend MA; Chubb P
    Nephrology (Carlton); 2009 Jun; 14(4):383-8. PubMed ID: 19563379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of post renal transplant hyperparathyroidism.
    Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 13. [The development of calcium metabolic disorders in patients in the terminal stage of chronic kidney failure receiving hemodialysis treatment].
    Kalashnikov AIa; Kon'kova TA; Popovkin NN; Iarmolinskiĭ IS
    Urol Nefrol (Mosk); 1989; (3):46-52. PubMed ID: 2773181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the calcium correct? Measuring serum calcium in dialysis patients.
    Morton AR; Garland JS; Holden RM
    Semin Dial; 2010; 23(3):283-9. PubMed ID: 20492582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM
    Clin Ther; 1999 Mar; 21(3):432-41. PubMed ID: 10321413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium metabolism and hyperparathyroidism after renal transplantation.
    Cundy T; Kanis JA; Heynen G; Morris PJ; Oliver DO
    Q J Med; 1983; 52(205):67-78. PubMed ID: 6348830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-corrected or ionized calcium in renal failure? What to measure?
    Gøransson LG; Skadberg Ø; Bergrem H
    Nephrol Dial Transplant; 2005 Oct; 20(10):2126-9. PubMed ID: 16030044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A method of calculating complexed calcium in patients with in-vitro simulated hypo- and hypercalcemia].
    Sokolova TIu; Pronchenko IA; Ermakova IP
    Klin Lab Diagn; 1993; (6):19-22. PubMed ID: 8032774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.